Women and Parkinson's Archives

Women and Parkinson's

To mark International Women’s Day, we share our campaign highlights
READ MORE
Women and Parkinson's

Have you heard about these Parkinson’s technology inventions?
READ MORE
Women and Parkinson's

Manon Day on being a young black woman with Parkinson’s
READ MORE

“We still have some way to go”

To mark International Women’s Day, we share our campaign highlights

The women blazing the trail in Parkinson’s tech and innovation

Have you heard about these Parkinson’s technology inventions?

“Incompetence, racism and prejudice delayed my diagnosis”

Manon Day on being a young black woman with Parkinson’s

7 famous women with Parkinson’s

Can you name a well-known woman with Parkinson’s?

“Recognising gender difference is essential for Parkinson’s research”

The research gap, revealed by neurologist Marina Picillo

“We need to be having more conversations about menopause”

One woman’s story about the approach of menopause

Women and Parkinson’s: menstruation, medication and motherhood

Our podcast shines a light on how women experience the condition

Women and Parkinson’s: “Being pregnant was scary”

One woman’s poignant account of pregnancy and Parkinson’s

Women and Parkinson’s: “My medication only works three weeks out of four”

An honest account of menstruation, medication and symptoms

“We are not just variants of men”

Our new campaign centres the experiences of women with Parkinson’s

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds. The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s. Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s. “Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”

Could playing table tennis help reduce Parkinson’s symptoms?

Researchers at Fukuoka University, Japan, have found that playing table tennis may help alleviate motor symptoms in Parkinson’s. As part of the study, 12 people with Parkinson’s with an average age of 73 played a five-hour session of table tennis every week for a period of six months. The sessions were developed specifically for people with the condition by experienced table tennis players from the university’s department of sports science. The participants were evaluated after three months and at the end of the study. At both evaluations, participants had reduced symptoms – showing improvement in speech, handwriting, walking and hand tremors. Two participants reported side-effects of backache and falling. Study author Ken-ichi Inoue, MD, of Fukuoka University said: “While this study is small, the results are encouraging because they show ping pong, a relatively inexpensive form of therapy, may improve some symptoms of Parkinson’s disease. A much larger study is…

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Women and Parkinson’s

“We still have some way to go”

The women blazing the trail in Parkinson’s tech and innovation

“Incompetence, racism and prejudice delayed my diagnosis”